We now observed a B cell-driven profile in the CSF of N-CTD patients with increased B cells, plasma cells, and intrathecal IgG, IgA, and IgM synthesis, which partially overlapped with the well-established CSF immune profile in MS [44, 45]. The gene discussed is CD79A; the disease is myeloid sarcoma.